General Information of Drug Off-Target (DOT) (ID: OTGTH90I)

DOT Name Cytochrome b-245 chaperone 1 (CYBC1)
Synonyms Essential for reactive oxygen species protein; Eros
Gene Name CYBC1
Related Disease
Attention deficit hyperactivity disorder ( )
Colitis ( )
Granulomatous disease, chronic, autosomal recessive, 5 ( )
Neoplasm of mature B-cells ( )
Respiratory syncytial virus infection ( )
Chronic granulomatous disease ( )
UniProt ID
CYBC1_HUMAN
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
Pfam ID
PF15169
Sequence
MYLQVETRTSSRLHLKRAPGIRSWSLLVGILSIGLAAAYYSGDSLGWKLFYVTGCLFVAV
QNLEDWEEAIFDKSTGKVVLKTFSLYKKLLTLFRAGHDQVVVLLHDVRDVSVEEEKVRYF
GKGYMVVLRLATGFSHPLTQSAVMGHRSDVEAIAKLITSFLELHCLESPTELSQSSDSEA
GDPASQS
Function
Functions as a chaperone necessary for a stable expression of the CYBA and CYBB subunits of the cytochrome b-245 heterodimer. Controls the phagocyte respiratory burst and is essential for innate immunity.
Tissue Specificity Highly expressed in macrophages, neutrophils and monocytes.

Molecular Interaction Atlas (MIA) of This DOT

6 Disease(s) Related to This DOT
Disease Name Disease ID Evidence Level Mode of Inheritance REF
Attention deficit hyperactivity disorder DISL8MX9 Strong Biomarker [1]
Colitis DISAF7DD Strong Biomarker [2]
Granulomatous disease, chronic, autosomal recessive, 5 DISMSEDG Strong Autosomal recessive [3]
Neoplasm of mature B-cells DISKAXO0 Strong Genetic Variation [4]
Respiratory syncytial virus infection DIS7FWHY Strong Genetic Variation [5]
Chronic granulomatous disease DIS9ZR24 Supportive Autosomal recessive [2]
------------------------------------------------------------------------------------
⏷ Show the Full List of 6 Disease(s)
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DOT
1 Drug(s) Affected the Post-Translational Modifications of This DOT
Drug Name Drug ID Highest Status Interaction REF
Valproate DMCFE9I Approved Valproate increases the methylation of Cytochrome b-245 chaperone 1 (CYBC1). [6]
------------------------------------------------------------------------------------
9 Drug(s) Affected the Gene/Protein Processing of This DOT
Drug Name Drug ID Highest Status Interaction REF
Ciclosporin DMAZJFX Approved Ciclosporin decreases the expression of Cytochrome b-245 chaperone 1 (CYBC1). [7]
Tretinoin DM49DUI Approved Tretinoin increases the expression of Cytochrome b-245 chaperone 1 (CYBC1). [8]
Cupric Sulfate DMP0NFQ Approved Cupric Sulfate decreases the expression of Cytochrome b-245 chaperone 1 (CYBC1). [9]
Estradiol DMUNTE3 Approved Estradiol increases the expression of Cytochrome b-245 chaperone 1 (CYBC1). [10]
Ivermectin DMDBX5F Approved Ivermectin decreases the expression of Cytochrome b-245 chaperone 1 (CYBC1). [11]
Quercetin DM3NC4M Approved Quercetin decreases the expression of Cytochrome b-245 chaperone 1 (CYBC1). [12]
Demecolcine DMCZQGK Approved Demecolcine decreases the expression of Cytochrome b-245 chaperone 1 (CYBC1). [13]
Genistein DM0JETC Phase 2/3 Genistein increases the expression of Cytochrome b-245 chaperone 1 (CYBC1). [10]
Benzo(a)pyrene DMN7J43 Phase 1 Benzo(a)pyrene increases the expression of Cytochrome b-245 chaperone 1 (CYBC1). [14]
------------------------------------------------------------------------------------
⏷ Show the Full List of 9 Drug(s)

References

1 Early-Onset Efficacy and Safety Pilot Study of Amphetamine Extended-Release Oral Suspension in the Treatment of Children with Attention-Deficit/Hyperactivity Disorder.J Child Adolesc Psychopharmacol. 2019 Feb;29(1):2-8. doi: 10.1089/cap.2018.0078. Epub 2018 Dec 21.
2 A homozygous loss-of-function mutation leading to CYBC1 deficiency causes chronic granulomatous disease. Nat Commun. 2018 Oct 25;9(1):4447. doi: 10.1038/s41467-018-06964-x.
3 Eros is a novel transmembrane protein that controls the phagocyte respiratory burst and is essential for innate immunity. J Exp Med. 2017 Apr 3;214(4):1111-1128. doi: 10.1084/jem.20161382. Epub 2017 Mar 28.
4 Genome-wide association study identifies five susceptibility loci for follicular lymphoma outside the HLA region.Am J Hum Genet. 2014 Oct 2;95(4):462-71. doi: 10.1016/j.ajhg.2014.09.004.
5 Interaction between healthcare professionals and parents is a key determinant of parental distress during childhood hospitalisation for respiratory syncytial virus infection (European RSV Outcomes Study [EROS]).Acta Paediatr. 2018 May;107(5):854-860. doi: 10.1111/apa.14224. Epub 2018 Feb 12.
6 Integrative omics data analyses of repeated dose toxicity of valproic acid in vitro reveal new mechanisms of steatosis induction. Toxicology. 2018 Jan 15;393:160-170.
7 Integrating multiple omics to unravel mechanisms of Cyclosporin A induced hepatotoxicity in vitro. Toxicol In Vitro. 2015 Apr;29(3):489-501.
8 Transcriptional and Metabolic Dissection of ATRA-Induced Granulocytic Differentiation in NB4 Acute Promyelocytic Leukemia Cells. Cells. 2020 Nov 5;9(11):2423. doi: 10.3390/cells9112423.
9 Physiological and toxicological transcriptome changes in HepG2 cells exposed to copper. Physiol Genomics. 2009 Aug 7;38(3):386-401.
10 Genistein and bisphenol A exposure cause estrogen receptor 1 to bind thousands of sites in a cell type-specific manner. Genome Res. 2012 Nov;22(11):2153-62.
11 Quantitative proteomics reveals a broad-spectrum antiviral property of ivermectin, benefiting for COVID-19 treatment. J Cell Physiol. 2021 Apr;236(4):2959-2975. doi: 10.1002/jcp.30055. Epub 2020 Sep 22.
12 Comparison of phenotypic and transcriptomic effects of false-positive genotoxins, true genotoxins and non-genotoxins using HepG2 cells. Mutagenesis. 2011 Sep;26(5):593-604.
13 Characterization of formaldehyde's genotoxic mode of action by gene expression analysis in TK6 cells. Arch Toxicol. 2013 Nov;87(11):1999-2012.
14 Comparison of HepG2 and HepaRG by whole-genome gene expression analysis for the purpose of chemical hazard identification. Toxicol Sci. 2010 May;115(1):66-79.